Six consecutive cases of successful adult ABO-incompatible living donor liver transplantation: A proposal for grading the severity of antibody-mediated rejection

Transplantation

Volumn 85, Issue 2, 2008, Pages 171-178

  Morioka, Daisuke ^a   Togo, Shinji ^a   Kumamoto, Takafumi ^a   Takeda, Kazuhisa ^a   Matsuo, Ken Ichi ^a   Inayama, Yoshiaki ^a   Yamanaka, Shoji ^a   Tanaka, Kuniya ^a   Endo, Itaru ^a   Maegawa, Jiro ^a   Shimada, Hiroshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

ABO incompatible; Antibody mediated rejection; Immunosuppression; Living donor liver transplantation

Indexed keywords

ANTIBODY; AZATHIOPRINE; CD20 ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GABEXATE MESILATE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NAFAMSTAT MESILATE; PROSTAGLANDIN E1; TACROLIMUS;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD GROUP ABO INCOMPATIBILITY; BOLUS INJECTION; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG INFUSION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPROPHYLAXIS; JAUNDICE; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER HEMORRHAGE; LIVER TRANSPLANTATION; LIVING DONOR; MALE; NEUTROPHIL CHEMOTAXIS; OUTCOME ASSESSMENT; PLASMAPHERESIS; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; SPLENECTOMY; THROMBOCYTE COUNT;

ABO BLOOD-GROUP SYSTEM; BLOOD GROUP INCOMPATIBILITY; GRAFT REJECTION; HUMANS; IMMUNOGLOBULIN M; ISOANTIBODIES; JAUNDICE; LIVER TRANSPLANTATION; LIVING DONORS; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 38549134862     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31815e9672     Document Type: Article

References (21)

1. Takahashi K. Recent findings in ABO-incompatible kidney transplantation: Classification and therapeutic strategy for acute antibody-mediated rejection due to ABO-blood-group-related antigens during the critical period preceding the establishment of accommodation. Clin Exp Nephrol 2007; 11: 128.
2. Tyden G, Donauer J, Wadstrom J, et al. Implementation of a protocol for ABO-incompatible kidney transplantation- a three-center experience with 60 consecutive transplantations. Transplantation 2007; 83: 1153.
3. Ishida H, Miyamoto N, Shirakawa H, et al. Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation-single center analysis. Am J Transplant 2007; 7: 825.
4. Haga H, Egawa H, Fujimoto Y, et al. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation. Liver Transpl 2006; 12: 457.
5. Hanto DW, Fecteau AH, Alonso MH, et al. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy and quadruple immunosuppression: Evidence for accommodation. Liver Transpl 2003; 9: 22.
6. Troisi R, Noses L, Montalti R, et al. ABO-mismatch adult living donor liver transplantation using antigen-specific immunoadsorption and quadruple immunosuppression without splenectomy. Liver Transpl 2006; 12: 1412.
7. Demetris AJ, Jaffe R, Tzakis A, et al. Antibody-mediated rejection of human orthotopic liver allograft.Astudy of liver transplantation across ABO blood group barriers. Am J Pathol 1988; 132: 489.
8. Gugenheim J, Samuel D, Reynes M, Bismuth H. Liver transplantation across ABO blood group barriers. Lancet 1990; 336: 519.
9. Morioka D, Sekido H, Kubota K, et al. Antibody-mediated rejection remedied by gamma-globulin bolus infusion combined with plasmapheresis. Transplantation 2004; 78: 1225.
10. Yoshizawa A, Sakamoto S, Ogawa K, et al. New protocol of immunosuppression for liver transplantation across ABO barrier: The use of Rituximab, hepatic arterial infusion, and preservation of spleen. Transplant Proc 2005; 37: 1718.
11. Wamer PR, Nester TA. ABO-incompatible solid-organ transplantation. Am J Clin Pathol. 2006; 125, Suppl: S87.
12. Haga H, Egawa H, Shirase T, et al. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation. Liver Transpl 2004; 10: 16.
13. Tanabe M, Shimazu M, Wakabayashi G, et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 2002; 73: 1959.
14. Oike F, Kamei H, Tanaka K. Novel approaches for ABO blood-type incompatible liver transplantation from living donor: Intraportal infusion therapy and hepatic arterial infusion therapy. Kon-nichi no Ishoku 2003; 16: 479.
15. Onaca NN, Levy MF, Netto GJ, et al. Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am J Transplant 2003; 3: 626.
16. Sawada T, Fuchinoue S, Teraoka S. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis. Transplantation 2002; 74: 1207.
17. Keck T, Balcom JH, Antoniu BA, et al. Regional effects of nafamostat, a novel potent protease and complement inhibitor, on severe necrotizing pancreatitis. Surgery 2001; 130: 175.
18. Sekido H, Matsuo K, Takeda K, et al. Successful adult ABO-incompatible liver transplantation: Therapeutic strategy for thrombotic microangiopathy is the key to success. Transplantation 2003; 75: 1605.
19. Egawa H, Oike F, Buhler L, et al. Impact of recipient age on outcomes of ABO-incompatible living-donor liver transplantation. Transplantation 2004; 77: 403.
20. Rull R, Garcia Valdecasas JC, et al. Intrahepatic biliary lesions after orthotopic liver transplantation. Transpl Int 2001; 14: 129.
21. Fan ST, Lo CM, Liu CL, et al. Biliary reconstruction and complications of right lobe live donor liver transplantation. Ann Surg 2002; 236: 676.